Medscape, LLC requires every individual in a position to control educational content to disclose all financial relationships with ineligible companies that have occurred within the past 24 months. Ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

All relevant financial relationships for anyone with the ability to control the content of this educational activity are listed below and have been mitigated according to Medscape policies. Others involved in the planning of this activity have no relevant financial relationships.

Faculty

Trisha Suppes, MD, PhD

Professor, Psychiatry and Behavioral Sciences
Stanford University School of Medicine
Stanford, California
Director, CSP NODES Program
VA Palo Alto Health Care System
Palo Alto, California

Disclosures

Disclosure: Trisha Suppes, MD, PhD, has the following relevant financial relationships:
Advisor or consultant for: Impel NeuroPharma Inc.; Intracellular Therapies; Sunovion Pharmaceuticals, Inc.
Speaker or a member of a speakers bureau for: Servier (Australia); Sunovion Pharmaceuticals, Inc.
Grants for clinical research from: Merck

Joseph F. Goldberg, MD

Professor of Psychiatry
Icahn School of Medicine at Mount Sinai
New York, New York

Disclosures

Disclosure: Joseph F. Goldberg, MD, has the following relevant financial relationships:
Advisor or consultant for: BioXcel; Jazz Pharmaceuticals; Lundbeck; Otsuka; Sage Pharmaceuticals; Sunovion
Speaker or a member of a speakers bureau for: AbbVie; Alkermes; Sunovion

Editor

Clinton W. Wright, PharmD, BCPP

Medical Education Director, Medscape, LLC

Disclosures

Disclosure: Clinton W. Wright, PharmD, BCPP, has disclosed no relevant financial relationships.

Compliance Reviewer/Nurse Planner

Leigh Schmidt, MSN, RN, CMSRN, CNE, CHCP

Associate Director, Accreditation and Compliance, Medscape, LLC

Disclosures

Disclosure: Leigh Schmidt, MSN, RN, CMSRN, CNE, CHCP, has no relevant financial relationships.

Peer Reviewer

This activity has been peer reviewed and the reviewer has disclosed no relevant financial relationships.

CME / CE

Treatments for Bipolar Depression: Where We Are and Where We Are Going

Authors: Trisha Suppes, MD, PhD; Joseph F. Goldberg, MD
CME / CE Released: 2/4/2022
THIS ACTIVITY HAS EXPIRED
Valid for credit through: 2/4/2023

Start Activity

Target Audience and Goal Statement

This activity is intended for psychiatrists, nurses, nurse practitioners, physicians assistants in psychiatry, and other clinicians who treat patients with bipolar depression.

The goal of this activity is to improve the diagnosis and treatment of patients with bipolar depression.

Upon completion of this activity, participants will:

Have increased knowledge regarding the
- FDA approved status of medications for bipolar depression
- Differences in mechanisms of action among current and emerging treatments for bipolar depression
- Clinical data on emerging treatments for bipolar depression

Disclosures

Faculty

Trisha Suppes, MD, PhD

Professor, Psychiatry and Behavioral Sciences
Stanford University School of Medicine
Stanford, California
Director, CSP NODES Program
VA Palo Alto Health Care System
Palo Alto, California

Disclosures

Disclosure: Trisha Suppes, MD, PhD, has the following relevant financial relationships:
Advisor or consultant for: Impel NeuroPharma Inc.; Intracellular Therapies; Sunovion Pharmaceuticals, Inc.
Speaker or a member of a speakers bureau for: Servier (Australia); Sunovion Pharmaceuticals, Inc.
Grants for clinical research from: Merck

Joseph F. Goldberg, MD

Professor of Psychiatry
Icahn School of Medicine at Mount Sinai
New York, New York

Disclosures

Disclosure: Joseph F. Goldberg, MD, has the following relevant financial relationships:
Advisor or consultant for: BioXcel; Jazz Pharmaceuticals; Lundbeck; Otsuka; Sage Pharmaceuticals; Sunovion
Speaker or a member of a speakers bureau for: AbbVie; Alkermes; Sunovion

Editor

Clinton W. Wright, PharmD, BCPP

Medical Education Director, Medscape, LLC

Disclosures

Disclosure: Clinton W. Wright, PharmD, BCPP, has disclosed no relevant financial relationships.

Compliance Reviewer/Nurse Planner

Leigh Schmidt, MSN, RN, CMSRN, CNE, CHCP

Associate Director, Accreditation and Compliance, Medscape, LLC

Disclosures

Disclosure: Leigh Schmidt, MSN, RN, CMSRN, CNE, CHCP, has no relevant financial relationships.

Peer Reviewer

This activity has been peer reviewed and the reviewer has disclosed no relevant financial relationships.

Accreditation Statements

In support of improving patient care, Medscape, LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

For Physicians

Medscape, LLC designates this enduring material for a maximum of 0.50 AMA PRA Category 1 Credit(s)™ . Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Contact This Provider

For Nurses

Awarded 0.50 contact hour(s) of nursing continuing professional development for RNs and APNs; 0.50 contact hours are in the area of pharmacology.

Contact This Provider

For questions regarding the content of this activity, contact the accredited provider for this CME/CE activity noted above. For technical assistance, contact [email protected]

Instructions for Participation and Credit

There are no fees for participating in or receiving credit for this online educational activity. For information on applicability and acceptance of continuing education credit for this activity, please consult your professional licensing board.

This activity is designed to be completed within the time designated on the title page; physicians should claim only those credits that reflect the time actually spent in the activity. To successfully earn credit, participants must complete the activity online during the valid credit period that is noted on the title page. To receive AMA PRA Category 1 Credit™, you must receive a minimum score of 75% on the post-test.

Follow these steps to earn CME/CE credit*:

Read the target audience, learning objectives, and author disclosures.
Study the educational content online or printed out.
Online, choose the best answer to each test question. To receive a certificate, you must receive a passing score as designated at the top of the test. We encourage you to complete the Activity Evaluation to provide feedback for future programming.

You may now view or print the certificate from your CME/CE Tracker. You may print the certificate but you cannot alter it. Credits will be tallied in your CME/CE Tracker and archived for 6 years; at any point within this time period you can print out the tally as well as the certificates from the CME/CE Tracker.

*The credit that you receive is based on your user profile.

From Medscape Education Psychiatry & Mental Health

CME / CE

Treatments for Bipolar Depression: Where We Are and Where We Are Going

Authors: Trisha Suppes, MD, PhD; Joseph F. Goldberg, MDFaculty and Disclosures

THIS ACTIVITY HAS EXPIRED

CME / CE Released: 2/4/2022

Valid for credit through: 2/4/2023

processing....

A Powerpoint version of the slides from this presentation
is available for use as a professional resource from Medscape Education.

Download Now

CME / CE Information

Activity Transcript

Print
Like Tweet

Activity Transcript

Disclaimer

The educational activity presented above may involve simulated, case-based scenarios. The patients depicted in these scenarios are fictitious and no association with any actual patient, whether living or deceased, is intended or should be inferred. The material presented here does not necessarily reflect the views of Medscape, LLC, or any individuals or commercial entities that support companies that support educational programming on medscape.org. These materials may include discussion of therapeutic products that have not been approved by the US Food and Drug Administration, off-label uses of approved products, or data that were presented in abstract form. These data should be considered preliminary until published in a peer-reviewed journal. Readers should verify all information and data before treating patients or employing any therapies described in this or any educational activity. A qualified healthcare professional should be consulted before using any therapeutic product discussed herein.

Faculty and Disclosures

Faculty

Trisha Suppes, MD, PhD

Joseph F. Goldberg, MD

Editor

Clinton W. Wright, PharmD, BCPP

Compliance Reviewer/Nurse Planner

Leigh Schmidt, MSN, RN, CMSRN, CNE, CHCP

Peer Reviewer

CME / CE

Treatments for Bipolar Depression: Where We Are and Where We Are Going

Target Audience and Goal Statement

Disclosures

Faculty

Trisha Suppes, MD, PhD

Joseph F. Goldberg, MD

Editor

Clinton W. Wright, PharmD, BCPP

Compliance Reviewer/Nurse Planner

Leigh Schmidt, MSN, RN, CMSRN, CNE, CHCP

Peer Reviewer

Accreditation Statements

For Physicians

For Nurses

Instructions for Participation and Credit

Treatments for Bipolar Depression: Where We Are and Where We Are Going